肥胖和肺癌 - 编程死亡配体-1 (PD-1L) 表达是否存在联系?
Jakub Krzysztof Gałązka1, Marcin Czeczelewski2, Tomasz Kucharczyk3
1Students' Scientific Association at Chair of Clinical Oncology and Chemotherapy, Medical University of Lublin, Lublin, Poland.
肥胖可能会改变肺癌细胞中编程死亡配体-1 (PD-1L) 的表达,特别是在女性中. 超重女性与正常体重女性相比,PD-1L表达有显著差异.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 肥胖与慢性炎症和免疫反应的改变有关.
- 编程死亡联体-1 (PD-1L) 在癌细胞的免疫逃避中起着至关重要的作用.
- 肥胖诱导的免疫调节对肺癌中PD-1L表达的影响尚不清楚.
研究的目的:
- 调查肥胖与肺癌细胞中编程死亡配体-1 (PD-1L) 表达之间的关联.
- 为了确定肥胖诱导的免疫调节是否会影响肺癌中的PD-1L表达.
主要方法:
- 追溯的横截面研究设计.
- 包括67名肺癌患者.
- 与身体质量指数 (BMI) 相比,对编程死亡-1 (PD-1L) 表达的分析.
主要成果:
- 在超重和正常体重妇女之间观察到PD-1L表达的统计学上显著差异 (p=0.040).
- ANOVA测试表明女性表达的显著差异 (p=0.050).
- 在整体患者组或组织学子组中,PD-1L表达和BMI之间没有发现显著的相关性.
结论:
- 与肥胖相关的免疫调节可能会影响肺癌中PD-1L的表达,特别是在女性中.
- 研究结果表明,在肺癌中,体重状况和PD-1L表达之间存在潜在的性别特异关系.
- 需要进一步的研究来阐明机制和临床影响.
更多相关视频
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
相关概念视频
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Obesity
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
